Close

Search

Search Menu
Photonics Media Photonics Buyers' Guide Photonics EDU Photonics Spectra BioPhotonics EuroPhotonics Industrial Photonics Photonics Showcase Photonics ProdSpec Photonics Handbook
More News
share
Email Facebook Twitter Google+ LinkedIn Comments

Drug discovery

BioPhotonics
May 2008
Promega_DrugDiscovery.jpgIssue 20 of “Cell Notes,” a serial publication of Promega Corp., focuses on drug discovery and screening. The 32-page document includes an article on monitoring viability during gene-directed enzyme prodrug therapy with the CellTiter-Glo assay and human neural progenitor cells, and a discussion on detecting toxicological responses in cells with the bioluminescent GSH-Glo glutathione assay. Other articles address screening traditional Chinese medicines, RNAi knockdown in primary cells, cytochrome P450 activity in rat hepatocytes cultured on a synthetic extracellular matrix, and high-throughput kinase and multiplex cytotoxity assays. Publications that cite the use of Promega reagents and technologies in novel high-throughput screening applications are highlighted.


BiophotonicsBreakthroughMediacellsenzyme prodrug therapyNew MediaPromega Corp.toxicological responses

Comments
Terms & Conditions Privacy Policy About Us Contact Us
back to top

Facebook Twitter Instagram LinkedIn YouTube RSS
©2018 Photonics Media, 100 West St., Pittsfield, MA, 01201 USA, info@photonics.com
x Subscribe to BioPhotonics magazine - FREE!
We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.